3D-(6-acyl) PHADTM | 699855
Monophosphoryl Hexa-acyl Lipid A, 3-Deacyl (Synthetic)
All Prices in US Dollars
Quantity discounts may be available at the 5 and 10 count level.
Contact customer service for a quote.
Add your chosen unit to the shopping cart and adjust the quantity to see the discount.
To purchase larger quantities of this product please contact our Customer Service Department
- Vaccination is well-accepted as an effective method to prevent infections by mounting pathogen-specific immune responses prior to the infection. Usually, immunization with vaccine antigens alone is not able to induce robust or long-lasting immune responses — resulting in failure of protective immunity against infections. Thus, adjuvants are required to enhance cellular or humoral immune responses upon immunization. Because vaccine adjuvants using Lipid A have proven to be safe and effective in inducing Th-1 type immune responses to heterologous proteins in animal and human vaccines, Avanti developed Phosphorylated HexaAcyl Disaccharide (PHAD®), the first fully synthetic monophosphoryl Lipid A available for use as an adjuvant in human vaccines.
Adjuvant ActivityPHAD®, 3D-PHAD®, and 3D(6A)-PHAD® have been tested extensively in animals using a variety of antigens. In all cases, these adjuvants exhibit a similar activity and safety profile to bacterially-derived MPL. The data above demonstrate the equivalency of the three synthetic adjuvants to the bacterially-derived MPL when presented in a liposomal carrier system (DMPC/DMPG/Cholesterol).
- Molecular Formula
- Percent Composition
- C 65.98%, H 10.61%, N 2.40%, O 19.23%, P 1.77%
- 1 year
- Molecular Weight
- Exact Mass